<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A case of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) is reported </plain></SENT>
<SENT sid="1" pm="."><plain>A 48-year-old man visited our hospital because of <z:hpo ids='HP_0000093'>proteinuria</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>He had suffered from <z:mp ids='MP_0005048'>thrombosis</z:mp> and had high titers of antibodies to beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (abeta2GPI) and anticardiolipin antibodies (aCLIgG) and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>We started anticoagulation therapy using <z:chebi fb="8" ids="10033">warfarin</z:chebi> combined with <z:chebi fb="2" ids="8378">prednisolone</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Although platelet count was improved, the titers of anti-beta2GPI and aCLIgG still remained high </plain></SENT>
<SENT sid="5" pm="."><plain>Therefore, double-filtration plasmapheresis (DFPP) was carried out to remove the antibodies </plain></SENT>
<SENT sid="6" pm="."><plain>After the treatment with DFPP, <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> was administered </plain></SENT>
<SENT sid="7" pm="."><plain>These therapies resulted in lower titers of abeta2GPI and aCLIgG and no more <z:mp ids='MP_0005048'>thrombosis</z:mp> occurred </plain></SENT>
<SENT sid="8" pm="."><plain>A combination therapy using <z:chebi fb="8" ids="10033">warfarin</z:chebi>, <z:chebi fb="2" ids="8378">prednisolone</z:chebi>, <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> and DFPP might be effective for the treatment of patients with APS </plain></SENT>
</text></document>